AAP
MLAB icon

Arax Advisory Partners’s Mesa Laboratories MLAB Stock Holding History

Arax Advisory Partners’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
1,455
+725
+99% +$73K ﹤0.01% 2464
2026
Q1 		$64.6K Buy
730
+38
+5% +$3.27K ﹤0.01% 1576
2025
Q4 		$54.3K Buy
692
+77
+13% +$5.86K ﹤0.01% 1566
2025
Q3 		$41.2K Buy
615
+103
+20% +$7.41K ﹤0.01% 1921
2025
Q2 		$48.2K Sell
512
-3
-0.6% -$329 ﹤0.01% 1254
2025
Q1 		$61.1K Sell
515
-6
-1% -$818 ﹤0.01% 881
2024
Q4 		$68.7K Sell
521
-7
-1% -$859 ﹤0.01% 801
2024
Q3 		$68.5K Buy
528
+1
+0.2% +$118 0.01% 603
2024
Q2 		$45.7K Buy
527
+19
+4% +$1.99K ﹤0.01% 694
2024
Q1 		$55.7K Buy
508
+1
+0.2% +$101 0.01% 474
2023
Q4 		$53.1K Hold
507
– – 0.01% 465
2023
Q3 		$53.2K Buy
507
+1
+0.2% +$128 0.01% 457
2023
Q2 		$65K Sell
506
-53
-9% -$8.08K 0.01% 424
2023
Q1 		$97.6K Buy
559
+1
+0.2% +$179 0.01% 350
2022
Q4 		$92.7K Sell
558
-278
-33% -$43.6K 0.01% 346
2022
Q3 		$118K Hold
836
– – 0.02% 288
2022
Q2 		$170K Buy
836
+1
+0.1% +$219 0.03% 234
2022
Q1 		$213K Buy
835
+150
+22% +$40.7K 0.03% 237
2021
Q4 		$225K Buy
685
+332
+94% +$104K 0.03% 229
2021
Q3 		$107K Hold
353
– – 0.01% 316
2021
Q2 		$96K Buy
+353
New +$89.5K 0.01% 344
2020
Q4 		$101K Hold
353
– – 0.01% 298
2020
Q3 		$90K Hold
353
– – 0.02% 282
2020
Q2 		$77K Hold
353
– – 0.01% 292
2020
Q1 		$80K Buy
353
+118
+50% +$29.1K 0.02% 267
2019
Q4 		$59K Buy
+235
New +$55K 0.02% 316

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arax Advisory Partners's MLAB Position: Q2 2026 in Review

Arax Advisory Partners increased its Mesa Laboratories (MLAB) stake by 99% in Q2 2026, buying an estimated $73K and bringing the position to 1,455 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Arax Advisory Partners first reported a position in MLAB in Q4 2019 and has held it in 26 quarters since. The position peaked at $225K in Q4 2021. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Arax Advisory Partners held 1,455 shares of Mesa Laboratories worth $145K as of Q2 2026.
  • Arax Advisory Partners bought 725 Mesa Laboratories shares in Q2 2026, an estimated $73K.
  • Mesa Laboratories made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2464 holding.
  • Arax Advisory Partners first reported a position in Mesa Laboratories in Q4 2019 and has held it in 26 quarters since.
  • Arax Advisory Partners's Mesa Laboratories position peaked at $225K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.